Defects in growth hormone receptor signaling
- 30 June 2007
- journal article
- Published by Elsevier in Trends in Endocrinology & Metabolism
- Vol. 18 (4), 134-141
- https://doi.org/10.1016/j.tem.2007.03.004
Abstract
No abstract availableKeywords
This publication has 62 references indexed in Scilit:
- Endocrine assessment, molecular characterization and treatment of growth hormone insensitivity disordersNature Clinical Practice Endocrinology & Metabolism, 2006
- Germline KRAS mutations cause Noonan syndromeNature Genetics, 2006
- Model for growth hormone receptor activation based on subunit rotation within a receptor dimerNature Structural & Molecular Biology, 2005
- A Gain-of-Function Mutation ofJAK2in Myeloproliferative DisordersNew England Journal of Medicine, 2005
- A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia veraNature, 2005
- Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 MutationScience, 2001
- Mutation of the SHP-2 Binding Site in Growth Hormone (GH) Receptor Prolongs GH-Promoted Tyrosyl Phosphorylation of GH Receptor, JAK2, and STAT5BMolecular Endocrinology, 2000
- Defective Thymocyte Maturation in p44 MAP Kinase (Erk 1) Knockout MiceScience, 1999
- Xid -Like Immunodeficiency in Mice with Disruption of the p85α Subunit of Phosphoinositide 3-KinaseScience, 1999
- Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinaseMolecular Endocrinology, 1996